Kumud Kalia - Net Worth and Insider Trading
Kumud Kalia Net Worth
The estimated net worth of Kumud Kalia is at least $492,905 dollars as of 2023-03-23. Kumud Kalia is the Chief Information Officer of Guardant Health Inc and owns about 20,135 shares of Guardant Health Inc (GH) stock worth over $492,905. Details can be seen in Kumud Kalia's Latest Holdings Summary section.
Transaction Summary of Kumud Kalia
Kumud Kalia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kumud Kalia owns 1 companies in total, including Guardant Health Inc (GH) .
Click here to see the complete history of Kumud Kalia’s form 4 insider trades.
Insider Ownership Summary of Kumud Kalia
|Ticker||Comapny||Transaction Date||Type of Owner|
|GH||Guardant Health Inc||2022-05-01||Chief Information Officer|
Kumud Kalia Latest Holdings Summary
Kumud Kalia currently owns a total of 1 stock. Kumud Kalia owns 20,135 shares of Guardant Health Inc (GH) as of November 15, 2022, with a value of $492,905.
Latest Holdings of Kumud Kalia
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
|GH||Guardant Health Inc||2022-11-15||20,135||24.48||492,905|
Holding Weightings of Kumud Kalia
Kumud Kalia Form 4 Trading Tracker
According to the SEC Form 4 filings, Kumud Kalia has made a total of 2 transactions in Guardant Health Inc (GH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Guardant Health Inc is the sale of 3,125 shares on November 15, 2022, which brought Kumud Kalia around $162,094.
Insider Trading History of Kumud Kalia
Kumud Kalia Trading Performance
Kumud Kalia Ownership Network
Ownership Network List of Kumud Kalia
Ownership Network Relation of Kumud Kalia
Kumud Kalia Owned Company Details
What does Guardant Health Inc do?
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
Who are the key executives at Guardant Health Inc?
Kumud Kalia is the Chief Information Officer of Guardant Health Inc. Other key executives at Guardant Health Inc include SVP & People Amelia Merrill , Chief Commercial Officer Chris Freeman , and CHIEF MEDICAL OFFICER Craig Eagle .
Guardant Health Inc (GH) Insider Trades Summary
Over the past 18 months, Kumud Kalia made 2 insider transaction in Guardant Health Inc (GH) with a net sale of 5,125. Other recent insider transactions involving Guardant Health Inc (GH) include a net sale of 24,670 shares made by Stanley J Meresman , a net purchase of 201,500 shares made by Amirali Talasaz , and a net purchase of 197,552 shares made by Helmy Eltoukhy .
In summary, during the past 3 months, insiders sold 0 shares of Guardant Health Inc (GH) in total and bought 190,052 shares, with a net purchase of 190,052 shares. During the past 18 months, 38,795 shares of Guardant Health Inc (GH) were sold and 399,052 shares were bought by its insiders, resulting in a net purchase of 360,257 shares.
Guardant Health Inc (GH)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:GH Insider Transactions
Kumud Kalia Mailing Address
Above is the net worth, insider trading, and ownership report for Kumud Kalia. You might contact Kumud Kalia via mailing address: 505 Penobscot Drive, Redwood City Ca 94063.